{"id":"https://openalex.org/W7220847794","doi":"https://doi.org/10.3389/fmed.2026.1927209","title":"Efficacy analysis and adverse event management of selinexor in the treatment of relapsed/refractory multiple myeloma","display_name":"Efficacy analysis and adverse event management of selinexor in the treatment of relapsed/refractory multiple myeloma","publication_year":2026,"publication_date":"2026-10-06","ids":{"openalex":"https://openalex.org/W7220847794","doi":"https://doi.org/10.3389/fmed.2026.1927209","pmid":"https://pubmed.ncbi.nlm.nih.gov/42909298","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13684124"},"language":"en","primary_location":{"id":"doi:10.3389/fmed.2026.1927209","doi":"https://doi.org/10.3389/fmed.2026.1927209","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1927209","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1927209/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1927209/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157819341","display_name":"Zengli Kuang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zengli Kuang","raw_affiliation_strings":["Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang","institution_ids":["https://openalex.org/I4210113011"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157856747","display_name":"Yu Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yu Chen","raw_affiliation_strings":["Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang","institution_ids":["https://openalex.org/I4210113011"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032267961","display_name":"\u4efb\u7fe0\u7231","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113011","display_name":"Weifang People's Hospital","ror":"https://ror.org/01xd2tj29","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210113011"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Cuiai Ren","raw_affiliation_strings":["Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weifang People's Hospital, Shandong Second Medical University, Not applicable Weifang","institution_ids":["https://openalex.org/I4210113011"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032267961"],"corresponding_institution_ids":["https://openalex.org/I4210113011"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.58850056,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":"1927209","last_page":"1927209"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/selective-inhibitor-of-nuclear-export","display_name":"selective inhibitor of nuclear export","score":0.8579999804496765},{"id":"https://openalex.org/keywords/xpo1","display_name":"CRM1","score":0.9039999842643738},{"id":"https://openalex.org/keywords/adverse-event-management","display_name":"adverse event management","score":0.7039999961853027},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9909999966621399},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.7870000004768372},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5870000123977661},{"id":"https://openalex.org/keywords/frail-older-patients","display_name":"frail elderly patients","score":0.7329999804496765},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8137000203132629},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6651999950408936},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6606000065803528},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.6399999856948853},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.4918000102043152},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.40130001306533813},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.36550000309944153},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.34360000491142273},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.34290000796318054},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.31619998812675476},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.31119999289512634},{"id":"https://openalex.org/C3020404979","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk stratification","level":2,"score":0.2994000017642975},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.28630000352859497}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fmed.2026.1927209","doi":"https://doi.org/10.3389/fmed.2026.1927209","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1927209","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1927209/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13684124","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13684124/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13684124/pdf/fmed-13-1927209.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Med (Lausanne)","raw_type":"Text"},{"id":"pmid:42909298","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42909298","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in medicine","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:f05096dc068648d1a1bd2a0b851d360d","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f05096dc068648d1a1bd2a0b851d360d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Medicine, Vol 13 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fmed.2026.1927209","doi":"https://doi.org/10.3389/fmed.2026.1927209","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fmed.2026.1927209","pdf_url":"https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1927209/pdf","source":{"id":"https://openalex.org/S2597052008","display_name":"Frontiers in Medicine","issn_l":"2296-858X","issn":["2296-858X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220847794.pdf","grobid_xml":"https://content.openalex.org/works/W7220847794.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W1828971193","https://openalex.org/W2046497407","https://openalex.org/W2066800926","https://openalex.org/W2094088075","https://openalex.org/W2104195581","https://openalex.org/W2159089429","https://openalex.org/W2161160225","https://openalex.org/W2462779032","https://openalex.org/W2610540653","https://openalex.org/W2794340145","https://openalex.org/W2921533600","https://openalex.org/W2950157870","https://openalex.org/W2969931905","https://openalex.org/W3008231845","https://openalex.org/W3010015692","https://openalex.org/W3015022394","https://openalex.org/W3047048853","https://openalex.org/W3087659808","https://openalex.org/W3103404395","https://openalex.org/W3105812043","https://openalex.org/W3134103265","https://openalex.org/W3215143226","https://openalex.org/W4210734847","https://openalex.org/W4223436767","https://openalex.org/W4282046936","https://openalex.org/W4283364239","https://openalex.org/W4285498552","https://openalex.org/W4310162538","https://openalex.org/W4318682974","https://openalex.org/W4324307861","https://openalex.org/W4376956687","https://openalex.org/W4379052430","https://openalex.org/W4385454386","https://openalex.org/W4386084534","https://openalex.org/W4388033801","https://openalex.org/W4388793761","https://openalex.org/W4388903160","https://openalex.org/W4389218804","https://openalex.org/W4390616036","https://openalex.org/W4391841288","https://openalex.org/W4392858017","https://openalex.org/W4393183615","https://openalex.org/W4396589257","https://openalex.org/W4399775192","https://openalex.org/W4400662806","https://openalex.org/W4404473433","https://openalex.org/W4405869573","https://openalex.org/W4405892608","https://openalex.org/W4407176824","https://openalex.org/W4408060576","https://openalex.org/W4409716082","https://openalex.org/W4411154016","https://openalex.org/W4411491713","https://openalex.org/W4411857672","https://openalex.org/W4413453621","https://openalex.org/W4413970563","https://openalex.org/W4414159575","https://openalex.org/W4414401476","https://openalex.org/W4417013872"],"related_works":["https://openalex.org/W4393021318","https://openalex.org/W4414159575","https://openalex.org/W7135084099","https://openalex.org/W2993536872","https://openalex.org/W3097529202","https://openalex.org/W3162720179","https://openalex.org/W3163518321","https://openalex.org/W3172884862","https://openalex.org/W4384461310","https://openalex.org/W4393183615"],"abstract_inverted_index":{"The":[0,128],"treatment":[1,46,150],"of":[2,35,61,63,145],"relapsed/refractory":[3],"multiple":[4],"myeloma":[5],"(RRMM)":[6],"remains":[7],"a":[8,20,44,135],"significant":[9],"clinical":[10,71,85],"challenge,":[11],"particularly":[12],"for":[13,52,107,139,152],"patients":[14],"with":[15,94,134],"multidrug":[16],"resistance,":[17],"who":[18],"have":[19],"poor":[21],"prognosis":[22],"and":[23,65,77,90,142],"limited":[24],"therapeutic":[25],"options.":[26],"Selinexor,":[27],"as":[28,74,124],"the":[29,40,59,75,140],"world's":[30],"first":[31],"oral":[32],"selective":[33],"inhibitor":[34],"nuclear":[36],"export":[37],"(SINE),":[38],"targets":[39],"XPO1":[41],"protein,":[42],"offering":[43],"novel":[45],"mechanism":[47,60],"distinct":[48],"from":[49,69],"traditional":[50],"agents":[51],"RRMM.":[53],"This":[54],"narrative":[55],"review":[56],"systematically":[57],"synthesizes":[58],"action":[62],"Selinexor":[64],"critically":[66],"evaluates":[67],"evidence":[68],"key":[70],"studies":[72],"(such":[73,123],"STORM":[76],"BOSTON":[78],"trials).":[79],"It":[80,100],"focuses":[81],"on":[82],"discussing":[83],"its":[84,91,108],"positioning":[86],"across":[87],"different":[88],"scenarios":[89],"combination":[92],"strategies":[93,117],"commonly":[95],"used":[96],"regimens":[97],"(e.g.,":[98,112],"SVd).":[99],"also":[101],"addresses":[102],"standardized,":[103],"proactive":[104],"management":[105],"pathways":[106],"characteristic":[109],"adverse":[110],"effects":[111],"thrombocytopenia,":[113],"gastrointestinal":[114],"reactions).":[115],"These":[116],"are":[118],"tailored":[119],"to":[120,131,148],"patient":[121],"stratification":[122],"triple-/penta-refractory,":[125],"elderly/frail":[126],"patients).":[127],"aim":[129],"is":[130],"provide":[132],"clinicians":[133],"practical,":[136],"evidence-based":[137],"reference":[138],"safe":[141],"effective":[143],"application":[144],"this":[146],"drug":[147],"optimize":[149],"outcomes":[151],"RRMM":[153],"patients.":[154]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-08T00:00:00"}